Seung-Hwan Jeong

Seung-Hwan Jeong

Auto-generated profile, based on publicly available information

Seung-Hwan Jeong

Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2021 in Science Advances
Verified
Journal Article
Open access
WLWonryung Lee
Wonryung Lee
SJSeung-Hwan Jeong
Seung-Hwan Jeong
YLYoung-Woo Lim
Young-Woo Lim
HLHyunhwan Lee
Hyunhwan Lee
JKJoohyuk Kang
Joohyuk Kang
BBByeong-Soo Bae
Byeong-Soo Bae
A conformable microneedle biochemical detection platform that can diagnose metabolic disease has been developed.

15 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
HCHyunsik Choi
Hyunsik Choi
SJSeung-Hwan Jeong
Seung-Hwan Jeong
CSCristina Simó
Cristina Simó
ABAnna Bakenecker
Anna Bakenecker
JLJordi Liop
Jordi Liop
Sei Kwang HahnSei Kwang Hahn
Sei Kwang Hahn
Most non-muscle invasive bladder cancers have been treated by transurethral resection and following intravesical injection of immunotherapeutic agents. However, the delivery efficiency of therapeutic agents into bladder wall is low due to frequent urination, which leads to the failure of treatment with side effects. Here, we report a urease-powered nanomotor containing the agonist of stimulator of interferon genes (STING) for the efficient activation of immune cells in the bladder wall. After characterization, we perform in vitro motion analysis and assess in vivo swarming behaviors of nanomotors. The intravesical instillation results in the effective penetration and retention of nanomotors in the bladder. In addition, we confirm the anti-tumor effect of nanomotor containing the STING agonist (94.2% of inhibition), with recruitment of CD8+ T cells (11.2-fold compared with PBS) and enhanced anti-tumor immune responses in bladder cancer model in female mice. Furthermore, we demonstrate the better anti-tumor effect of nanomotor containing the STING agonist than those of the gold standard Bacille Calmette-Guerin therapy and the anti-PD-1 inhibitor pembrolizumab in bladder cancer model. Taken together, the urease-powered nanomotor would provide a paradigm as a next-generation platform for bladder cancer immunotherapy.

1 January 2023 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
SJSeung-Hwan Jeong
Seung-Hwan Jeong
JKJa Hyun Ku
Ja Hyun Ku
Jeong SH, et al. Investig Clin Urol. 2023 Mar;64(2):103-106. https://doi.org/10.4111/icu.20230042

1 January 2022 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
SJSeung-Hwan Jeong
Seung-Hwan Jeong
CKCheol Kwak
Cheol Kwak
Jeong SH, et al. Investig Clin Urol. 2022 Jan;63(1):3-13. https://doi.org/10.4111/icu.20210369

10 June 2022 in Science Advances
Verified
Journal Article
Open access
JBJung Hyun Bae
Jung Hyun Bae
MYMyung Jin Yang
Myung Jin Yang
SJSeung-Hwan Jeong
Seung-Hwan Jeong
JKJungMo Kim
JungMo Kim
SHSeon Pyo Hong
Seon Pyo Hong
GKGou Young Koh
Gou Young Koh
In sprouting angiogenesis, the precise mechanisms underlying how intracellular vascular endothelial growth factor receptor 2 (VEGFR2) signaling is higher in one endothelial cell (EC) compared with its neighbor and acquires the tip EC phenotype under a similar external cue are elusive. Here, we show that Merlin, encoded by the neurofibromatosis type 2 ( NF2 ) gene, suppresses VEGFR2 internalization depending on VE-cadherin density and inhibits tip EC induction. Accordingly, endothelial Nf2 depletion promotes tip EC induction with excessive filopodia by enhancing VEGFR2 internalization in both the growing and matured vessels. Mechanistically, Merlin binds to the VEGFR2–VE-cadherin complex at cell-cell junctions and reduces VEGFR2 internalization–induced downstream signaling during tip EC induction. As a consequence, nonfunctional excessive sprouting occurs during tumor angiogenesis in EC-specific Nf2 -deleted mice, leading to delayed tumor growth. Together, Nf2 /Merlin is a crucial molecular gatekeeper for tip EC induction, capillary integrity, and proper tumor angiogenesis by suppressing VEGFR2 internalization.

1 January 2022 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
KLKyeongchae Lee
Kyeongchae Lee
SJSeung-Hwan Jeong
Seung-Hwan Jeong
SYSang-Hyun Yoo
Sang-Hyun Yoo
JKJa Hyun Ku
Ja Hyun Ku
Lee K, et al. Investig Clin Urol. 2021 Dec;63:e6. https://doi.org/10.4111/icu.20210314